TEPADINA

Product NDC
70121-2749
11-digit product format
701212749
Labeler code
70121
Product ID
70121-2749_4f44c872-f02d-48cc-b2a4-4e05d2422b72
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
thiotepa
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
Labeler
Amneal Pharmaceuticals LLC
Application
NDA208264
Marketing category
NDA
Marketing start
2025-04-18
Substance
THIOTEPA
Active strength
200 mg/1
Pharmacologic classes
Alkylating Activity [MoA], Alkylating Drug [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
905Z5W3GKHTHIOTEPA52-24-4THIOTEPA

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70121-2749-1701212749011 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (70121-2749-1) 2025-04-18NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
TEPADINAAmneal Pharmaceuticals LLC | Adienne S.r.l. | BSP Pharmaceuticals SpA | CIT SRL | Eurofins Biolab Srl | Indena SpA | LabAnalysis Life Science srl | NerPharMa S.r.l2026-01-30HUMAN PRESCRIPTION DRUG LABEL30
TEPADINAAmneal Pharmaceuticals LLC | Adienne S.r.l. | BSP Pharmaceuticals SpA | CIT SRL | Eurofins Biolab Srl | Indena SpA | LabAnalysis Life Science srl | NerPharMa S.r.l2025-10-15HUMAN PRESCRIPTION DRUG LABEL27
TEPADINAAmneal Pharmaceuticals LLC | Adienne S.r.l. | BSP Pharmaceuticals SpA | CIT SRL | Eurofins Biolab Srl | Indena SpA | LabAnalysis Life Science srl | NerPharMa S.r.l2025-04-24HUMAN PRESCRIPTION DRUG LABEL25